Recent blog posts
LY6G6D Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6d Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LY6G6D Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6d Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LY6G6D protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LRP4 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LRP4 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LRP5 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LRP5 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
INSR Biologics Sequence Review Report 2026: Insulin receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
INSR Biologics Sequence Review Report 2026: Insulin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of INSR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
RARRES1 Biologics Sequence Review Report 2026: Retinoic acid receptor responder protein 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
RARRES1 Biologics Sequence Review Report 2026: Retinoic acid receptor responder protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RARRES1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MBL2 Biologics Sequence Review Report 2026: Mannose-binding protein C Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MBL2 Biologics Sequence Review Report 2026: Mannose-binding protein C Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MBL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GRM5 Biologics Sequence Review Report 2026: Metabotropic glutamate receptor 5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GRM5 Biologics Sequence Review Report 2026: Metabotropic glutamate receptor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRM5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
FCN3 Biologics Sequence Review Report 2026: Ficolin-3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
FCN3 Biologics Sequence Review Report 2026: Ficolin-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FCN3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
FOLR3 Biologics Sequence Review Report 2026: Folate receptor gamma Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
FOLR3 Biologics Sequence Review Report 2026: Folate receptor gamma Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FOLR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GDF5 Biologics Sequence Review Report 2026: Growth/differentiation factor 5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GDF5 Biologics Sequence Review Report 2026: Growth/differentiation factor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GDF5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
VIPR2 Biologics Sequence Review Report 2026: Vasoactive intestinal polypeptide receptor 2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
VIPR2 Biologics Sequence Review Report 2026: Vasoactive intestinal polypeptide receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of VIPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ACHE Biologics Sequence Review Report 2026: Acetylcholinesterase Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ACHE Biologics Sequence Review Report 2026: Acetylcholinesterase Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ACHE protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →